Kolexia
Saillard Colombe Hématologie
Saillard Colombe
Hématologie
Centre Paoli-Calmettes
Marseille, France
97 Activités
342 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Maladie grave Tumeurs hématologiques Leucémie-lymphome lymphoblastique à précurseurs B et T Maladie du greffon contre l'hôte Insuffisance respiratoire Lymphomes

Collaborateurs

Voir plus
Vey Norbert
Vey Norbert
Centre Paoli-Calmettes, Marseille, France
Rey Jerome
Rey Jerome
Centre Paoli-Calmettes, Marseille, France
Mokart Djamel
Mokart Djamel
Centre Paoli-Calmettes, Marseille, France
Blaise Didier
Blaise Didier
Centre Paoli-Calmettes, Marseille, France

Industries

Voir plus
MSD
1 collaboration(s)
Dernière en 2022
B3TSI
1 collaboration(s)
Dernière en 2023
Amgen
1 collaboration(s)
Dernière en 2023
Novartis
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup
Essai Clinique (Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH)   22 février 2024
Long-term survival of AML treated with intensive chemotherapy with extensive molecular data available.
Leukemia & lymphoma   08 février 2024
Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients.
European journal of haematology   29 novembre 2023
Preliminary Results of a Phase 1, First-in-Human Study of INA03, an Anti-CD71 Antibody-Drug Conjugate in Patients with Relapsed or Refractory (R/R) Acute Leukemias
65th ASH Annual Meeting Abstracts   02 novembre 2023
Clinical, Cytogenetic and Molecular Characterization of a 96 MDS and AML Cohort with TP53 Mutation
65th ASH Annual Meeting Abstracts   02 novembre 2023
Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with Venetoclax-Azacitidine (VEN-AZA) for Newly Diagnosed Acute Myeloid Leukemia. a Multicentric Real-Life Study of 117 Patients
65th ASH Annual Meeting Abstracts   02 novembre 2023
Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes: A Phase I/II, Open-label, Single Arm, Multicenter Dose-finding Study Assess the Safety and Preliminary Efficacy of Oral Azacitidine CC-486 (ONUREG) in Combination With Venetoclax (VENCLYXTO) in Previously Untreated Higher-risk Myelodysplastic Syndromes Ineligible for Allogenic Transplantation
Essai Clinique (BMS)   25 octobre 2023
Disseminated Scedosporium Invasive Fungal Infection in Critically ill Newly Diagnosed Acute Myeloid Leukemia Patient Complicated with Cerebritis.
Mycopathologia   10 octobre 2023
Characteristics and outcomes of patients with acute myeloid leukemia admitted to intensive care unit with acute respiratory failure: a post-hoc analysis of a prospective multicenter study.
Annals of intensive care   02 septembre 2023
POSTER: AML-110 Outcome of Acute Myeloid Leukemia Relapse After Allogenic Stem Cell Transplantation: A Single-Institution Retrospective Study
Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting   01 septembre 2023